Allan Kjer has been appointed as business support director at Peterborough-based medical devices company Coloplast.   It is Danish-born Allan’s fourth job with the company. After working in finance jobs for Nordea Bank and Thomas Cook in Copenhagen he joined Coloplast as treasurer in 2006. His subsequent career with the company has seen him working …

January 5, 2012   Contact: Megale Public Relations at (347) 92-STARS or (347) 927-8277 E Mail: info@mediaproductions.tv   A Social Media Strategy in Times Square Boasts Great Results for TheraMax Cold and Flu (New York, NY) – TheraBiogen Inc. (TRAB:OTCBB), creator of TheraMaxtm Cold and Flu utilized the busy holiday season underneath their billboard in …

  METTLER TOLEDO recently published a white paper entitled "Process Analytical Technology (PAT) for Biotech: A Review of Recently Reported Applications in Fermentation and Bioprocessing." The paper explores how Process Analytical Technologies, or PATs, help optimize fermentation and bioprocess actions critical to pharmaceutical, specialty chemical, commodity chemical, and bulk fuel development and manufacturing.   "PAT …

September 27th 2011 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, announced today that it would be working with the editorial team of European Pharmaceutical Manufacturer magazine to supply expert opinion on the regulatory affairs industry. ELC GROUP’s Advisory Board member, Dr. Paolo Biffignandi MD, PhD, QPPV, FTOPRA, will write the regular column. Dr. …

According to our latest report, “Global Genetic Testing Market Analysis”, with the total contribution of around 15%, the global genetic testing market represents one of the leading applications of molecular diagnostics. Genetic testing is currently available to assess the risk of developing a wide range of medical conditions and consumers’ preferences to opt or not …

  According to our latest research report, “Booming Clinical Trials Market in India”, the spending of pharma companies in CDM runs into millions of dollars. Typically, data management costs account for 20-35% of the total cost of a clinical trial. As CDM is highly technology-driven and needs the use of IT systems; hence, pharma companies …

According to our latest report entitled, “Global Genetic Testing Market Analysis”, global genetic testing market witnessed a rapid growth rate in the recent years on the back of factors, such as increasing awareness level, rising prevalence of genetic disorders, and private sector participation. Recent industry developments and discovery of new genes are attracting a large …

According to our latest report, “Booming Generics Drug Market in India”, the Indian generics drug market has been growing at a rapid pace over the past few years. Despite the recession, the market continued to perform well and reached an estimated mark of US$ 17 Billion in FY 2010. Factors including patent expiries, increasing awareness …

As per our new research report, “Global Biosimilars Market Analysis”, the acceptability of biosimilars is very high in the Indian domestic market. Factors that are working favorably for Indian biosimilar companies are the relative cost advantage of biosimilar development compared to their competitors elsewhere; hence reducing appeal of imported biosimilars and relatively lowering of regulatory …

According to our new research report, “Asian Medical Tourism Analysis (2008-2012)”,  medical tourism is emerging as one of the fastest growing markets in Asia, with the rising number of foreign tourists coming for their treatments into the region. The main reasons for the growth of the industry include the low cost of treatments and the …

According to our latest research report, “Russian Pharma Sector Forecast to 2013”, the Government and other industrial regulatory bodies are taking numerous initiatives to ensure that the pharma industry in the country receives tremendous boost for the future. Understanding the pressing situation put forth by rising prevalence of lifestyle disease, such as diabetes, hypertension, cardiovascular …

RNCOS has recently published “Rite Aid Corporation – Company Analysis” The study provides an overview of the company’s history, businesses, its mergers and acquisitions, etc. It provides an insight into the products and services offered by the company for informing prospective clients about its product portfolio. The report also provides comprehensive financial information about the …

The prevalence of diabetes is less in China compared to other developed and developing nations, but as it houses the largest population in the world, it provides plethora of opportunities to the pharmaceutical players entering in this market. Besides, amid increasing concerns towards health and increasing awareness about chronic diseases, like diabetes among the consumers, …

RNCOS has recently published “Ranbaxy Laboratories Limited – Company Analysis” The study provides an overview of the company’s history, businesses, its mergers and acquisitions, etc. It provides an insight into the products and services offered by the company for informing prospective clients about its product portfolio. The report also provides comprehensive financial information about the …

RNCOS has recently published “Bayer AG – Company Analysis” The study provides an overview of the company’s history, businesses, its mergers and acquisitions, etc. It provides an insight into the products and services offered by the company for informing prospective clients about its product portfolio. The report also provides comprehensive financial information about the company …

The US generics market has shown a solid growth during the past few years backed by factors, such as government support, increasing awareness level, patent expiry of blockbuster drugs, price differences, and aging population. The generic drugs industry in the US stood at US$ 74 Billion in 2009, and is likely to grow further at …

According to our research “US e-health Market Analysis”, e-Health market has evolved as one of the fastest growing industries in the US during the last few years. The market has strongly benefited from the government’s strong desire to diminish the massive healthcare expenditures. Infact, e-Health being the most prominent source of cost containment is being …

The only non-corneal and non-contact  Tonometer DIATON now enables optometrists and other healthcare professionals who provide primary vision care to test intraocular pressure (IOP) for glaucoma Through the EYELID. Quick and painless, handheld Diaton pen-like tonometer readings are not affected by contact lenses or other corneal properties. BiCOM Inc., home of tonometer Diaton is proud …

As per our new research report “Global Telemedicine Market Analysis”, rural areas in most of the countries face various problems in the provision of medical services and health care, including funds, expertise, and resources. To meet this challenge, the governments and private health care providers are making use of existing resources and the benefits of …

According to our research report “Indian Pharma Sector Forecast 2014”, the Indian pharmaceutical industry is moving towards the adoption and development of generic drugs, which will help it to grow at a CAGR of around 15% during FY 2012-FY 2014. Despite factors, such as increasing urbanization and personal disposable income, a large share of people …

The European Commission proposed the implementation of Paediatric Investigation Plans (PIPs) to help ensure that treatments for children are included in the mainstream drug development process in Europe, rather than as an elective extra. SMi Group provides a CPD accredited Masterclass which aims to address the problems encountered during the creation of a PIP, as …

The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that …

The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that …

SMi Group’s CPD accredited Social Media: Our Past, Present and the Future of Digital Health Online masterclass provides industry professionals with the tools needed to plan, execute and fully incorporate social media as part of your pharmaceutical firm’s effective overall online digital strategy.   Social media’s potential as a tool to raise awareness in healthcare …

Massive changes have occurred over the last decade in the pharmaceutical industry and have consequently led to a period of transition, which has necessitated a change in approach. The previous blockbuster model was showing cracks, and reps were no longer seen as the solution to a lot of problems. SMi’s CPD accredited Masterclass gives industry …

For biotech ideas to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment. SMi Group provides a CPD accredited masterclass which helps delegates and their firms ensure IP success by …

Biosimilar medicines are already a commercial reality in the European Union.  The U.S. Healthcare Reform legislation – with its defined pathway for the regulatory approval of follow-on biologics – should open up the U.S. market in the future, but in the meantime, the next batch of biosimilars will face other difficulties in reaching the market, …

NEW YORK, N.Y., June 1, 2011 – A new Intelligence Report released today by CONTEXTWEB Inc., http://www.contextweb.com, a leading provider of integrated digital media services, reports that pharmaceutical advertisers can realize significant gains in campaign effectiveness and efficiency at scale by moving beyond a limited focus on premium health content. The report from CONTEXTWEB, entitled …

Our latest research offering “Middle East and Africa Pharma Sector Forecast to 2012”, depicts that the pharmaceutical industry in the region is undergoing a phase of dynamic change. The changes brought about by revolutionary initiatives taken by the government of the constituent nations will help the pharma industry to grow at an unprecedented rate. Various …

According to our latest report entitled “Japanese Generic Market Forecast to 2013”, the generic drugs market in Japan has been witnessing positive developments for the past few years. All the industry participants have been actively promoting the use of generic drugs across the country. Due to such positive developments, the generics market in Japan reached …